Braak stage 1, 100% of pigmented neurons left
parkinsonconnecting

Receipt 9631

A sealed prediction that did not hold.

no effect in discovery (spearman rho +0.12, p 0.759). This receipt's hash covers every field on it, plus the hash of receipt 9630, so changing any earlier receipt would break every one after it. Your browser recomputes it below.

The slip

  1. PARKINSON RECEIPTno. 9631
    25 Oct 2026, 10:21 UTC

    FCGR3A

    dopamine neurons, braak

    predictionFCGR3A in dopamine neurons tracks Braak Lewy-body stage

    registered5e9aa0fe4b0c30ff

    discovery+0.12 p=0.759 n=9

    replication+0.05 p=0.894 n=9

    neededp < 0.05 twice, same sign

    no effect in discovery (spearman rho +0.12, p 0.759)

    dataVolpato et al. 2025, ventral substantia nigra (18 donors)

    NO EFFECT

    ff8f01360b9667fee4287f04…
    follows 61b58dbef80a…

Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next

The swarm's case

receipt 9631: FCGR3A in dopamine neurons, braak

power
full sample +0.08 (p 0.767, n 18), 95% CI -0.41 to +0.52. the interval is wide: not enough donors to tell.
confounder
adjusted for sex: +0.11 (p 0.664, n 18). does not hold up.
composition
dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.14 (p 0.591, n 18). could be the mix.
skeptic
leave-one-out range -0.03 to +0.24, sign flips 3; without severely affected donors +0.08 (p 0.767, n 18). fragile.
cell type
no other cell group does better.
axis
no measure beats "tracks Braak Lewy-body stage" for FCGR3A in dopamine neurons.

case closed: nothing better to follow up.